Source: redaccionmedica.com The government has approved this Tuesday for 9.550.000 euros to attend the 2019 call for grants of the Strategic Plan for Research and Innovation […]
Source: immedicohospitalario.es Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized according to the most recent results of […]
Source: redaccionmedica.com The biopharmaceutical company Gilead Sciences continues its commitment to research in our country, this time, developing a project to achieve the cure of HIV. […]
Source: redaccionmedica.com Currently, the pharmaceutical industry has a total of 169 new drugs against breast cancer in the clinical research phase, a disease that encompasses the […]
Source: redaccionmedica.com Actelion Pharmaceuticals has announced the results of the first randomized controlled trial in portopulmonary hypertension (HTPP). This study has shown that Opsumit (macitentan) significantly […]
Source: actasanitaria.com The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast […]
Source: immedicohospitalario.es New ways of researching and developing drugs, in their most advanced oncological aspects, urge health administrations, hospitals, patients and their organizations, Research Ethics Committees […]
Source: redaccionmedica.com Researchers at the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona have achieved that immunotherapy attacks only the tumor cells of a type of […]
Source: IntraMed The American James Allison and the Japanese Tasuku Honjo have won the Nobel Prize for Medicine 2018. The jury of the Karolinska Institute in […]
Source: actasanitaria.com The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of the drug Gilenya (fingolimod), […]
Source: redaccionmedica.com The director of the Health Institute Carlos III (ISCIII), Raquel Yotti Álvarez, in charge of the head of the Spanish delegation at the opening […]
Source: Actasanitaria.com Within the framework of the 41st Annual Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM), which is being held in Santander, […]
Source: redaccionmedica.com The AstraZeneca Foundation, in collaboration with the Carlos III Health Institute, has announced the winners of the IV Young Researchers Awards, a recognition that […]
Distefar, considera que las funciones que se llevan a cabo en el servicio de farmacia hospitalaria, dentro del entorno de un estudio con medicamentos, son fundamentales […]
A Dutch team has developed a cell therapy for metastatic melanoma that improves on the current standard. Source: elespanol.com Researchers in the Netherlands and Denmark have […]
Representatives of scientific societies, public administrations, researchers and pharmaceutical companies make up the group. Clinical research at this level of care has a great opportunity for […]
Source: actasanitaria.com This report outlines the medicines already assessed by the Spanish Agency for Medicines and Health Products (AEMPS), which are considered to be of greatest interest […]
A study by Professor Lichtenberg of Columbia University attributes up to 96% of the increase in life expectancy in cancer patients and a high degree of […]
A report by the European Federation of the Pharmaceutical Industry (Efpia) insists that our continent has lost 25% of its weight in this area in the […]
Increased international competitiveness and digitalisation will require more investment in infrastructure and resources to ensure that our country remains at the forefront of biomedical R&D Source: […]
Farmaindustria explains to Esclerosis Múltiple Euskadi what these studies consist of, how to take part in them and how research into this pathology is progressing Source: […]
Aerospace and defence investment is eight times higher than in the aerospace and defence industry, seven times higher than in the chemical industry, and twice as […]
Oncology, infectious diseases, neurology, haematology and endocrinology are the areas with the highest number of clinical trials with new treatments underway. Seven out of ten molecules […]
Farmaindustria explains to some twenty experts some of the policies and initiatives that have made Spain an international benchmark in clinical drug trials Source: farmaindustria.es Representatives […]
Farmaindustria organises workshops with representatives of the Spanish Data Protection Agency and the Spanish Medicines Agency to continue working on the implementation of the new Code […]